LBF20303PG07: Difference between revisions
No edit summary |
No edit summary |
||
(12 intermediate revisions by 2 users not shown) | |||
Line 6: | Line 6: | ||
|LipidBank=XPR1797 | |LipidBank=XPR1797 | ||
|LipidMaps=- | |LipidMaps=- | ||
|SysName= | |SysName=(9alpha,11alpha,15S) -Trihydroxy- (8b) -prosta- (cis-5,trans-13,cis-17) -trien-1-oic acid | ||
|Common Name=&&8-iso Prostaglandin | |Common Name=&&8-iso Prostaglandin F_3 alpha&&(9alpha,11alpha,15S) -Trihydroxy- (8b) -prosta- (5Z,13E,17Z) -trien-1-oic acid&& | ||
|Source= | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
|Biological Activity=There is only one report on 8-iso PGF3 alpha showing inactive in a TP receptor mediated assay of human platelet shape change, where 8-iso PGF2 alpha has an ED50 value of 1 mu M.[[Reference:Pratico_D:Smyth_EM:Violi_F:FitzGerald_GA:,J. Biol. Chem.,1996,271,14916|{{RelationTable/GetFirstAuthor|Reference:Pratico_D:Smyth_EM:Violi_F:FitzGerald_GA:,J. Biol. Chem.,1996,271,14916}}]] | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} |
Latest revision as of 09:00, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1797 |
LipidMaps | - |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20303PG07 |
8-iso Prostaglandin F3α | |
---|---|
Structural Information | |
(9α,11α,15S) -Trihydroxy- (8b) -prosta- (cis-5,trans-13,cis-17) -trien-1-oic acid | |
| |
Formula | C20H32O5 |
Exact Mass | 352.224974134 |
Average Mass | 352.46508 |
SMILES | C(=CC[C@H](O)C=C[C@H]([C@@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC |
Physicochemical Information | |
There is only one report on 8-iso PGF3 alpha showing inactive in a TP receptor mediated assay of human platelet shape change, where 8-iso PGF2 alpha has an ED50 value of 1 mu M. Pratico_D et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|